Balakin KV - Search Results

1

Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.

Kravchenko DV, Kuzovkova YA, Kysil VM, Tkachenko SE, Maliarchouk S, Okun IM, Balakin KV, Ivachtchenko AV. Kravchenko DV, et al. Among authors: balakin kv. J Med Chem. 2005 Jun 2;48(11):3680-3. doi: 10.1021/jm048987t. J Med Chem. 2005. PMID: 15916416

2

Caspase activity modulators as anticancer agents.

Okun I, Balakin KV, Tkachenko SE, Ivachtchenko AV. Okun I, et al. Among authors: balakin kv. Anticancer Agents Med Chem. 2008 Apr;8(3):322-41. doi: 10.2174/187152008783961914. Anticancer Agents Med Chem. 2008. PMID: 18393791 Review.

3

Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides.

Zhuravel' IO, Kovalenko SM, Ivachtchenko AV, Balakin KV, Kazmirchuk VV. Zhuravel' IO, et al. Among authors: balakin kv. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5483-7. doi: 10.1016/j.bmcl.2005.08.081. Epub 2005 Sep 23. Bioorg Med Chem Lett. 2005. PMID: 16183276

4

Efficient optimization strategy for marginal hits active against abl tyrosine kinases.

Tkachenko SE, Okun I, Balakin KV, Petersen CE, Ivanenkov YA, Savchuk NP, Ivashchenko AA. Tkachenko SE, et al. Among authors: balakin kv. Curr Drug Discov Technol. 2004 Oct;1(3):201-10. doi: 10.2174/1570163043335018. Curr Drug Discov Technol. 2004. PMID: 16472247

5

Recent progress in discovery and development of antimitotic agents.

Kiselyov A, Balakin KV, Tkachenko SE, Savchuk N, Ivachtchenko AV. Kiselyov A, et al. Among authors: balakin kv. Anticancer Agents Med Chem. 2007 Mar;7(2):189-208. doi: 10.2174/187152007780058650. Anticancer Agents Med Chem. 2007. PMID: 17348827 Review.

6

Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.

Balakin KV, Ivanenkov YA, Kiselyov AS, Tkachenko SE. Balakin KV, et al. Anticancer Agents Med Chem. 2007 Sep;7(5):576-92. doi: 10.2174/187152007781668698. Anticancer Agents Med Chem. 2007. PMID: 17896917 Review.

7

Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinases.

Kiselyov A, Balakin KV, Tkachenko SE, Savchuk NP. Kiselyov A, et al. Among authors: balakin kv. Mini Rev Med Chem. 2006 Jun;6(6):711-7. doi: 10.2174/138955706777435698. Mini Rev Med Chem. 2006. PMID: 16787382 Review.

8

Property-based design of GPCR-targeted library.

Balakin KV, Tkachenko SE, Lang SA, Okun I, Ivashchenko AA, Savchuk NP. Balakin KV, et al. J Chem Inf Comput Sci. 2002 Nov-Dec;42(6):1332-42. doi: 10.1021/ci025538y. J Chem Inf Comput Sci. 2002. PMID: 12444729

9

Exploring the chemogenomic knowledge space with annotated chemical libraries.

Savchuk NP, Balakin KV, Tkachenko SE. Savchuk NP, et al. Among authors: balakin kv. Curr Opin Chem Biol. 2004 Aug;8(4):412-7. doi: 10.1016/j.cbpa.2004.06.003. Curr Opin Chem Biol. 2004. PMID: 15288252 Review.

10

CXCR4 receptor as a promising target for oncolytic drugs.

Lavrovsky Y, Ivanenkov YA, Balakin KV, Medvedeva DA, Ivachtchenko AV. Lavrovsky Y, et al. Among authors: balakin kv. Mini Rev Med Chem. 2008 Oct;8(11):1075-87. doi: 10.2174/138955708785909907. Mini Rev Med Chem. 2008. PMID: 18855724 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters